155 related articles for article (PubMed ID: 9581007)
1. The transition from injecting to smoking heroin in three Spanish cities. The Spanish Group for the Study of the Route of Heroin Administration.
de la Fuente L; Barrio G; Royuela L; Bravo MJ
Addiction; 1997 Dec; 92(12):1749-63. PubMed ID: 9581007
[TBL] [Abstract][Full Text] [Related]
2. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
de la Fuente L; Bravo MJ; Lew C; Barrio G; Soriano V; Royuela L
Med Clin (Barc); 1999 Nov; 113(17):646-51. PubMed ID: 10618778
[TBL] [Abstract][Full Text] [Related]
3. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
4. [Cohort study methodology of the ITINERE Project on heroin users in three Spanish cities and main characteristics of the participants].
de la Fuente de Hoz L; Brugal Puig MT; Ballesta Gómez R; Bravo Poetela MJ; Barrio Anta G; Domingo Salvany A; Silva do Rosario T; Ambrós Hortensi M;
Rev Esp Salud Publica; 2005; 79(4):475-91. PubMed ID: 16465964
[TBL] [Abstract][Full Text] [Related]
5. Cocaine use among heroin users in Spain: the diffusion of crack and cocaine smoking. Spanish Group for the Study on the Route of Administration of Drugs.
Barrio G; De la Fuente L; Royuela L; Díaz A; Rodríguez-Artalejo F
J Epidemiol Community Health; 1998 Mar; 52(3):172-80. PubMed ID: 9616422
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville.
Vallejo F; Toro C; de la Fuente L; Brugal MT; Soriano V; Silva TC; Bravo MJ; Ballesta R; Barrio G;
Eur Addict Res; 2008; 14(3):116-24. PubMed ID: 18552487
[TBL] [Abstract][Full Text] [Related]
7. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
[TBL] [Abstract][Full Text] [Related]
8. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic.
Bravo MJ; Barrio G; de la Fuente L; Royuela L; Domingo L; Silva T
Addiction; 2003 Jun; 98(6):749-60. PubMed ID: 12780363
[TBL] [Abstract][Full Text] [Related]
9. Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain.
Brugal MT; Pulido J; Toro C; de la Fuente L; Bravo MJ; Ballesta R; Soriano V; Barrio G; Vallejo F; Domingo-Salvany A; Castellano Y;
Eur Addict Res; 2009; 15(3):171-8. PubMed ID: 19506378
[TBL] [Abstract][Full Text] [Related]
10. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
11. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit".
de la Fuente L; Toro C; Brugal MT; Vallejo F; Soriano V; Barrio G; Ballesta R; Bravo MJ;
J Clin Virol; 2007 Jan; 38(1):87-90. PubMed ID: 17088099
[TBL] [Abstract][Full Text] [Related]
12. Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.
Gossop M; Stewart D; Marsden J; Kidd T; Strang J
Addict Behav; 2004 Aug; 29(6):1085-94. PubMed ID: 15236809
[TBL] [Abstract][Full Text] [Related]
13. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.
de la Fuente L; Bravo MJ; Toro C; Brugal MT; Barrio G; Soriano V; Vallejo F; Ballesta R;
J Epidemiol Community Health; 2006 Jun; 60(6):537-42. PubMed ID: 16698987
[TBL] [Abstract][Full Text] [Related]
14. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
15. [Changes in heroin administration route and frequency of human immunodeficiency virus infection].
Torres-Tortosa M; Ruiz López de Tejada MR; Fernández-Elías M; Pérez-Pérez C; Fernández-Conejero E; Ugarte I; Canueto J
Med Clin (Barc); 1995 Feb; 104(7):249-52. PubMed ID: 7731287
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
[TBL] [Abstract][Full Text] [Related]
17. Transitions between the injection of heroin and amphetamines.
Darke S; Kaye S; Ross J
Addiction; 1999 Dec; 94(12):1795-803. PubMed ID: 10717958
[TBL] [Abstract][Full Text] [Related]
18. Problematic heroin use incidence trends in Spain.
Sánchez-Niubò A; Fortiana J; Barrio G; Suelves JM; Correa JF; Domingo-Salvany A
Addiction; 2009 Feb; 104(2):248-55. PubMed ID: 19149821
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B vaccination: an unmet challenge in the era of harm reduction programs.
Vallejo F; Toro C; de la Fuente L; Brugal MT; Barrio G; Soriano V; Ballesta R; Bravo MJ;
J Subst Abuse Treat; 2008 Jun; 34(4):398-406. PubMed ID: 17869476
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors.
Barrio G; De La Fuente L; Toro C; Brugal TM; Soriano V; Gonzalez F; Bravo MJ; Vallejo F; Silva TC;
Epidemiol Infect; 2007 May; 135(4):592-603. PubMed ID: 17005071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
